<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(1)</volume><submitter>Chen X</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>As the most important pathophysiological process of obstructive sleep apnea (OSA), chronic intermittent hypoxia (CIH) could cause cognitive impairment. Our previous study showed that Shengmai Dihuang Decoction (SDD) improved CIH-induced cognitive impairment. However, the precise underlying mechanism remains unclear.&lt;h4>Objective&lt;/h4>This study aims to investigate the role of the insulin-like growth factor 1 (IGF1)/insulin-like growth factor 1 receptor (IGFR) signaling pathway in improving CIH-induced neuronal injury by SDD treatment.&lt;h4>Methods&lt;/h4>In this study, HT22 cells were cultured under CIH conditions (O&lt;sub>2&lt;/sub>: 21-0.1 %, 6 cycles/h). Cell ability was assessed by CCK-8 assay, and Mitochondrial damage was detected by transmission electron microscopy (TEM), mit</pubmed_abstract><journal>Journal of traditional and complementary medicine</journal><pagination>31-45</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12902252</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Role of IGF1/IGFR signaling pathway in neuroprotective effect of Shengmai Dihuang Decoction on CIH-induced cognitive impairment.</pubmed_title><pmcid>PMC12902252</pmcid><pubmed_authors>Sun M</pubmed_authors><pubmed_authors>Fan X</pubmed_authors><pubmed_authors>Qi K</pubmed_authors><pubmed_authors>Li D</pubmed_authors><pubmed_authors>Si J</pubmed_authors><pubmed_authors>Ji E</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Yang S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Role of IGF1/IGFR signaling pathway in neuroprotective effect of Shengmai Dihuang Decoction on CIH-induced cognitive impairment.</name><description>&lt;h4>Background&lt;/h4>As the most important pathophysiological process of obstructive sleep apnea (OSA), chronic intermittent hypoxia (CIH) could cause cognitive impairment. Our previous study showed that Shengmai Dihuang Decoction (SDD) improved CIH-induced cognitive impairment. However, the precise underlying mechanism remains unclear.&lt;h4>Objective&lt;/h4>This study aims to investigate the role of the insulin-like growth factor 1 (IGF1)/insulin-like growth factor 1 receptor (IGFR) signaling pathway in improving CIH-induced neuronal injury by SDD treatment.&lt;h4>Methods&lt;/h4>In this study, HT22 cells were cultured under CIH conditions (O&lt;sub>2&lt;/sub>: 21-0.1 %, 6 cycles/h). Cell ability was assessed by CCK-8 assay, and Mitochondrial damage was detected by transmission electron microscopy (TEM), mit</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-15T21:59:56.31Z</modification><creation>2026-07-09T10:20:11.916Z</creation></dates><accession>S-EPMC12902252</accession><cross_references><pubmed>41696739</pubmed><doi>10.1016/j.jtcme.2024.11.014</doi></cross_references></HashMap>